Significant Pathology Associated With Crossed Leg Sign

NCT01569555 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 400

Last updated 2012-04-03

No results posted yet for this study

Summary

By determining the correlation of a Crossed Leg Sign with signifcant pathology, a clinician would then be able to use this correlation to risk stratify his/her patients for significant pathology.

Conditions

  • Pathology

Sponsors & Collaborators

  • Uelk, J. Daniel, D.O.

    lead INDIV

Principal Investigators

  • John D Uelk, DO · Henry Ford Health System

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01569555 on ClinicalTrials.gov